| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Laboratory of Experimental Immunology,
Department of Pathology,
Laboratory of Experimental Transplantation, and
§
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium;
¶
Laboratory of Immunobiology, Rega Institute, University of Leuven, Leuven, Belgium; and
||
Tanox Pharma, Amsterdam, The Netherlands
Increased expression of CD40 and CD40 ligand (CD40L or CD154) has
been found in inflamed mucosa of human inflammatory bowel disease
(IBD), and interactions between these molecules seem to be involved in
local cytokine production by macrophages. However, the precise role of
CD40 signaling in the pathogenesis of IBD is still poorly understood.
The aim of the present study was to investigate the in vivo relevance
of CD40 signaling in experimental colitis in SCID mice reconstituted
with syngeneic CD45RBhighCD4+ T cells. The
results demonstrated that CD40+ and CD40L+
cells as well as their mRNA levels were significantly increased in
inflamed mucosa. Administration of anti-CD40L neutralizing mAb over
an 8-wk period starting immediately after
CD45RBhighCD4+ T cell reconstitution completely
prevented symptoms of wasting disease. Intestinal mucosal inflammation
was effectively prevented, as revealed by abrogated leukocyte
infiltration and decreased CD54 expression and strongly diminished mRNA
levels of the proinflammatory cytokines IFN-
, TNF, and IL-12. When
colitic SCID mice were treated with anti-CD40L starting at 5 wk
after T cell transfer up to 8 wk, this delayed treatment still led to
significant clinical and histological improvement and down-regulated
proinflammatory cytokine secretion. These data suggest that the
CD40-CD40L interactions are essential for the Th1 inflammatory
responses in the bowel in this experimental model of colitis. Blockade
of CD40 signaling may be beneficial to human
IBD.
This article has been cited by other articles:
|
|
 |
|
  X. Zhu, M. Wang, C. H. Crump, and A. Mishra An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G550 - G558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ito, T. Kanai, T. Totsuka, R. Okamoto, K. Tsuchiya, Y. Nemoto, A. Yoshioka, T. Tomita, T. Nagaishi, N. Sakamoto, et al. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G199 - G207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kim, M. Levin, S. P. Schoenberger, A. Sharpe, and M. Kronenberg Paradoxical Effect of Reduced Costimulation in T Cell-Mediated Colitis J. Immunol., May 1, 2007; 178(9): 5563 - 5570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Hellings, A. Kasran, D. Bullens, L. Overbergh, C. Mathieu, H. Heremans, P. Matthys, L. Boon, M. Jorissen, and J. L. Ceuppens IL-10- and IL-12-Independent Down-Regulation of Allergic Sensitization by Stimulation of CD40 Signaling J. Immunol., October 15, 2006; 177(8): 5138 - 5144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li and W. R. Green The Role of CD4 T Cells in the Pathogenesis of Murine AIDS. J. Virol., June 1, 2006; 80(12): 5777 - 5789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Danese, M. Sans, F. Scaldaferri, A. Sgambato, S. Rutella, A. Cittadini, J. M. Pique, J. Panes, J. A. Katz, A. Gasbarrini, et al. TNF-{alpha} Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn's Disease J. Immunol., February 15, 2006; 176(4): 2617 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Gao, A H Wagner, S Fankhaenel, T Stojanovic, S Schweyer, S Panzner, and M Hecker CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis Gut, January 1, 2005; 54(1): 70 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu and L. Lefrancois Intestinal Epithelial Antigen Induces Mucosal CD8 T Cell Tolerance, Activation, and Inflammatory Response J. Immunol., October 1, 2004; 173(7): 4324 - 4330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Danese, M Sans, and C Fiocchi The CD40/CD40L costimulatory pathway in inflammatory bowel disease Gut, July 1, 2004; 53(7): 1035 - 1043. [Full Text] [PDF]
|
|
|
|
 |
|
 K. G.-E. Scott, L. C. H. Yu, and A. G. Buret Role of CD8+ and CD4+ T Lymphocytes in Jejunal Mucosal Injury during Murine Giardiasis Infect. Immun., June 1, 2004; 72(6): 3536 - 3542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawamura, T. Kanai, T. Dohi, K. Uraushihara, T. Totsuka, R. Iiyama, C. Taneda, M. Yamazaki, T. Nakamura, T. Higuchi, et al. Ectopic CD40 Ligand Expression on B Cells Triggers Intestinal Inflammation J. Immunol., May 15, 2004; 172(10): 6388 - 6397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. P. de Jong, S. T. Rietdijk, W. A. Faubion, A. C. Abadia-Molina, K. Clarke, E. Mizoguchi, J. Tian, T. Delaney, S. Manning, J.-C. Gutierrez-Ramos, et al. Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis Int. Immunol., February 1, 2004; 16(2): 205 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bamias, C. Martin III, M. Marini, S. Hoang, M. Mishina, W. G. Ross, M. A. Sachedina, C. M. Friel, J. Mize, S. J. Bickston, et al. Expression, Localization, and Functional Activity of TL1A, a Novel Th1-Polarizing Cytokine in Inflammatory Bowel Disease J. Immunol., November 1, 2003; 171(9): 4868 - 4874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Danese, J A Katz, S Saibeni, A Papa, A Gasbarrini, M Vecchi, and C Fiocchi Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients Gut, October 1, 2003; 52(10): 1435 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C M Gelbmann, S N Leeb, D Vogl, M Maendel, H Herfarth, J Scholmerich, W Falk, and G Rogler Inducible CD40 expression mediates NF{kappa}B activation and cytokine secretion in human colonic fibroblasts Gut, October 1, 2003; 52(10): 1448 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Uraushihara, T. Kanai, K. Ko, T. Totsuka, S. Makita, R. Iiyama, T. Nakamura, and M. Watanabe Regulation of Murine Inflammatory Bowel Disease by CD25+ and CD25- CD4+ Glucocorticoid-Induced TNF Receptor Family-Related Gene+ Regulatory T Cells J. Immunol., July 15, 2003; 171(2): 708 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Marhaba, M. Bourouba, and M. Zoller CD44v7 interferes with activation-induced cell death by up-regulation of anti-apoptotic gene expression J. Leukoc. Biol., July 1, 2003; 74(1): 135 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson Curcumin attenuates DNB-induced murine colitis Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G235 - G243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Totsuka, T. Kanai, K. Uraushihara, R. Iiyama, M. Yamazaki, H. Akiba, H. Yagita, K. Okumura, and M. Watanabe Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G595 - G603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sharp, C. Thompson, E. T. Samy, R. Noelle, and K. S. K. Tung CD40 Ligand in Pathogenesis of Autoimmune Ovarian Disease of Day 3-Thymectomized Mice: Implication for CD40 Ligand Antibody Therapy J. Immunol., February 15, 2003; 170(4): 1667 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, K. Geboes, P. Hellings, P. Maerten, H. Heremans, P. Vandenberghe, L. Boon, P. van Kooten, P. Rutgeerts, and J. L. Ceuppens B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis J. Immunol., August 1, 2001; 167(3): 1830 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Kullberg, A. G. Rothfuchs, D. Jankovic, P. Caspar, T. A. Wynn, P. L. Gorelick, A. W. Cheever, and A. Sher Helicobacter hepaticus-Induced Colitis in Interleukin-10-Deficient Mice: Cytokine Requirements for the Induction and Maintenance of Intestinal Inflammation Infect. Immun., July 1, 2001; 69(7): 4232 - 4241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Malmstrom, D. Shipton, B. Singh, A. Al-Shamkhani, M. J. Puklavec, A. N. Barclay, and F. Powrie CD134L Expression on Dendritic Cells in the Mesenteric Lymph Nodes Drives Colitis in T Cell-Restored SCID Mice J. Immunol., June 1, 2001; 166(11): 6972 - 6981. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
